Tag: PsO

arthritis

Hope for chronic arthritis patients

0
Pharma major UCB has announced the European Commission approval for Bimzelx (bimekizumab), its humanized monoclonal IgG1 antibody. Bimzelx is said to exert simultaneous selective...